Lymphoma Rounds: Los Angeles

Sheraton Grand Los Angeles (click here for directions)
711 South Hope Street
Los Angeles, CA 90017

Thursday, February 27, 2020
6:30 PM – 9:00 PM

ACTIVITY CO-CHAIRS

Herbert Eradat, MD, MS
University of California, Los Angeles

Noah Merin, MD, PhD
Cedars-Sinai Medical Center

Sarah Tomassetti, MD
Harbor-UCLA Medical Center

This program is free for healthcare professionals; however, pre-registration is required. Food and refreshments will be provided for all registered participants.

Please note: Only representatives from supporting pharmaceutical companies are invited to register. If your company is interested in becoming a Lymphoma Rounds supporter please contact Sarah Quinlan, LRF, at squinlan@lymphoma.org.  Exhibit opportunities are also available, however, space is limited.

Companies that have secured a national exhibit sponsorship for Lymphoma Rounds must still rsvp by emailing Sarah Quinlan (squinlan@lymphoma.org) at least one week before the program to confirm their attendance. Otherwise, an exhibit table will not be guaranteed.

6:30 PM     Registration and Dinner Buffet

7:15 PM     Welcome

Cecilia Bouska, Lymphoma Research Foundation

7:30 PM     Splenic Marginal Zone Lymphoma

Shelly Gupta, MD, Harbor-UCLA Medical Center

Moderator
Sarah Tomassetti, MD, Harbor-UCLA Medical Center

8:00 PM    Chemorefractory p53 Overexpressor DLBCL Treated with CD3-CD20 Bispecific T Cell

Engager Followed by Allogeneic Stem Cell Transplantation

Arjan Gower, MD, Cedars-Sinai Medical Center

Pathology
Aaron Victor, MD, Cedars-Sinai Medical Center

Moderator
Noah Merin, MD, PhD, Cedars-Sinai Medical Center

8:30 PM    Secondary B-Cell ALL Transformed from Double Hit DLBCL

Daria Gaut, MD, University of California, Los Angeles

Moderator
Joshua Sasine, MD, PhD, University of California, Los Angeles

9:00 PM    Adjourn

ABOUT THE PROGRAM
The Lymphoma Rounds program provides a forum for local practicing physicians from academic and community medical centers to meet on a regular basis and address issues specific to the diagnosis and treatment of their lymphoma patients. Physicians network, share best practices and learn the latest information on new therapies and advances in the management of lymphoma through interactive case studies presented by lymphoma experts in the local area.

At the conclusion of this educational activity, the participant should be better able to:

  • Summarize the latest developments in lymphoma diagnosis, treatment and management.
  • Apply best practices for treating lymphoma patients.
  • Inform patients about potential clinical trial opportunities.
  • Establish a network of health care professionals who work with lymphoma patients.

Other dates in the 2019-20 Los Angeles Rounds series:

  • Thursday, April 23, 2020

Los Angeles Lymphoma Rounds Steering Committee

Cedars-Sinai Medical Center
Noah Merin, MD, PhD
City of Hope
Jasmine Zain, MD
Harbor-UCLA Medical Center
Sarah Tomassetti, MD
Southern California Permanente Medical Group
Kathy Pan, MD
University of California, Irvine
Elizabeth Brem, MD
Lauren Pinter-Brown, MD, FACP (chair)
University of California, Los Angeles
Herbert Eradat, MD, MS
University of Southern California
Ann Mohrbacher, MD

Joint Providership Statement

This activity has been planned and implemented in accordance with the Accreditation Requirements and Policies of the Accreditation Council for Continuing Medical Education through the joint providership of the University of Nebraska Medical Center, Center for Continuing Education and the Lymphoma Research Foundation.

Accreditation Statement

The University of Nebraska Medical Center, Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Statement

The University of Nebraska Medical Center, Center for Continuing Education designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit (s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Sponsors
Lymphoma Research Foundation and the University of Nebraska Medical Center, Center for Continuing Education

This activity is supported by educational grants from:
Acrotech Biopharma, LLC, AstraZeneca, Celgene Corporation, Janssen Scientific Affairs, LLC and Pharmacyclics, LLC, an AbbVie Company, Novartis Pharmaceuticals Corporation, Seattle Genetics, Inc., TG Therapeutics, Inc. and Verastem, Inc.